Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer

Published:2018-03-01 Issue:3 Volume:4 Page:351
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Mezquita Laura¹,Auclin Edouard²,Ferrara Roberto¹,Charrier Melinda³,Remon Jordi¹,Planchard David¹,Ponce Santiago⁴,Ares Luis Paz⁴,Leroy Laura⁵,Audigier-Valette Clarisse⁶,Felip Enriqueta⁷,Zerón-Medina Jorge⁷,Garrido Pilar⁸,Brosseau Solenn⁹,Zalcman Gérard⁹,Mazieres Julien¹⁰,Caramela Caroline¹¹,Lahmar Jihene¹,Adam Julien¹²,Chaput Nathalie³¹³,Soria Jean Charles¹⁴¹⁵,Besse Benjamin¹¹⁵

Affiliation:

1. Medical Oncology Department, Gustave Roussy, Villejuif, France

2. Medical and Gastrointestinal Oncology Department, Hôpital Européen Georges Pompidou, Paris, France

3. Laboratory of Immunomonitoring in Oncology, UMS 3655 CNRS/US 23 INSERM, Gustave Roussy, Villejuif, France

4. Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain

5. Medical Oncology Department, Institut Bergonie, Bordeaux, France

6. Pneumology Department, Centre Hospitalier Toulon Sainte-Musse, Toulon, France

7. Medical Oncology Department, Hospital Vall d’Hebron, Barcelona, Spain

8. Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain

9. Thoracic Oncology Department, CIC1425/CLIP2 Paris-Nord, Hôpital Bichat-Claude Bernard, Paris, France

10. Medical Oncology Department, Centre Hospitalier Universitaire de Toulouse, Toulouse, France

11. Radiology Department, Gustave Roussy, Villejuif, France

12. Pathology Department, Gustave Roussy, Villejuif, France

13. Faculty of Pharmacy, University Paris-Saclay, Chatenay-Malabry, France

14. Drug Development Department, Gustave Roussy, Villejuif, France

15. Faculty of Medicine, University Paris-Saclay, Le Kremlin Bicêtre, France

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 644 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck;Brazilian Journal of Otorhinolaryngology;2024-11

2. Clinical multi-dimensional prognostic nomogram for predicting the efficacy of immunotherapy in NSCLC;Scientific Reports;2024-09-13

3. Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer;Cell & Bioscience;2024-09-12

4. The application of lung immune prognostic index in predicting the prognosis of 302 STS patients;Frontiers in Oncology;2024-09-09

5. Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy;Clinical and Translational Oncology;2024-09-06